4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: July 8, 2020
Period of Report: July 5, 2020
Accession Number: 0001104659-20-082116

View Document ↗ View on SEC.gov ↗